The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
The Role of Overdiagnosis and Reclassification in the Marked Increase of Esophageal Adenocarcinoma Incidence
Abstract
BACKGROUND: The incidence of esophageal adenocarcinoma is rising dramatically. This increase may reflect increased disease burden, reclassification of related cancers, or overdiagnosis resulting from increased diagnostic intensity, particularly upper endoscopy for patients with gastroesophageal reflux disease or Barrett esophagus. METHODS: We used the National Cancer Institute's Surveillance, Epidemiology, and End Results database to extract information on incidence, stage distribution, and disease-specific mortality for esophageal adenocarcinoma as well as information on related cancers. RESULTS: From 1975 to 2001, the incidence of esophageal adenocarcinoma rose approximately sixfold in the United States (from 4 to 23 cases per million), a relative increase greater than that for melanoma, breast, or prostate cancer. Reclassification of squamous cell carcinoma is an unlikely explanation for the rise in incidence, because the anatomic distribution of esophageal cancer in general has changed. The only location with increased incidence is the lower third of the esophagus-the site where adenocarcinoma typically arises. Reclassification of adjacent gastric cancer is also unlikely because its incidence has also increased. Because there has been little change in the proportion of patients found with in situ or localized disease at diagnosis since 1975 (from 25% to 31%) and because esophageal adenocarcinoma mortality has increased more than sevenfold (from 2 to 15 deaths per million), overdiagnosis can be excluded as an explanation for the rise in incidence. CONCLUSION: The rising incidence of esophageal adenocarcinoma represents a real increase in disease burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., & Thun, M. J. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.8 · Cited by 3,984
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
Lagergren, J., Bergström, R., Lindgren, A., & Nyrén, O. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401101 · Cited by 3,020
Rising incidence of adenocarcinoma of the esophagus and gastric cardia
Blot, W. J. (1991) · JAMA · doi:10.1001/jama.265.10.1287 · Cited by 2,354
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
Devesa, S. S., Blot, W. J., & Fraumeni, J. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10<2049::aid-cncr1>3.0.co;2-2 · Cited by 2,115
Etzioni, R. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.13.981 · Cited by 949
Association between Body Mass and Adenocarcinoma of the Esophagus and Gastric Cardia
Lagergren, J., Bergström, R., & Nyrén, O. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00003 · Cited by 675
Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries
Botterweck, A. A., Schouten, L. J., Volovics, A., Dorant, E., & van den Brandt, P. A. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.4.645 · Cited by 537
Epidemiologic trends in esophageal and gastric cancer in the United States
Brown, L. M., & Devesa, S. S. (2002) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(02)00002-9 · Cited by 459
Ye, W., Held, M., Lagergren, J., Engstrand, L., Blot, W. J., McLaughlin, J. K., & Nyren, O. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh057 · Cited by 379
Adenocarcinoma of the Esophagus: Role of Obesity and Diet
Morris Brown, L., Swanson, C. A., Gridley, G., Swanson, G. M., Schoenberg, J. B., Greenberg, R. S., Silverman, D. T., Pottern, L. M., Hayes, R. B., Schwartz, A. G., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.2.104 · Cited by 373
Blaser, M. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314785 · Cited by 325
El-Serag, H. B., Mason, A. C., Petersen, N., & Key, C. R. (2002) · Gut · doi:10.1136/gut.50.3.368 · Cited by 261
Overdiagnosis: An Underrecognized Cause of Confusion and Harm in Cancer Screening
Black, W. C. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1280 · Cited by 242
Eloubeidi, M. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00228-4 · Cited by 222
Ekstrom, A. M., Signorello, L. B., Hansson, L.-E., Bergstrom, R., Lindgren, A., & Nyren, O. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.9.786 · Cited by 221
A case-control study of oesophageal adenocarcinoma in women: a preventable disease
Cheng, K. K., Sharp, L., McKinney, P. A., Logan, R. F. A., Chilvers, C. E. D., Cook-Mozaffari, P., Ahmed, A., & Day, N. E. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1121 · Cited by 191
The epidemic of esophageal adenocarcinoma
El‐Serag, H. B. (2002) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(02)00016-x · Cited by 124
Younes, M., Henson, D. E., Ertan, A., & Miller, C. C. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202762671215 · Cited by 113
Cited by
Pennathur, A., Gibson, M. K., Jobe, B. A., & Luketich, J. D. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60643-6 · Cited by 2,390
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
Wang, K. K., & Sampliner, R. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01835.x · Cited by 2,014
Welch, H. G., & Black, W. C. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq099 · Cited by 1,599
Self-citationRadiofrequency Ablation in Barrett's Esophagus with Dysplasia
Shaheen, N. J., Sharma, P., Overholt, B. F., Wolfsen, H. C., Sampliner, R. E., Wang, K. K., Galanko, J. A., Bronner, M. P., Goldblum, J. R., Bennett, A. E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808145 · Cited by 1,438
American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
Spechler, S. J., Sharma, P., Souza, R. F., Inadomi, J. M., & Shaheen, N. J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.031 · Cited by 1,060
Metadata
- Authors
- Pohl, H., & Welch, H. G.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-01-18
- Volume
- 97
- Issue
- 2
- Pages
- 142-146
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2122380766
- Cited by
- 1,270
- References
- 18
- FWCI
- 64.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.